Clever Leaves (OTCMKTS:CLEUF) is a vertically integrated producer of pharmaceutical-grade cannabis products, operating across cultivation, manufacturing and distribution. The company’s core business centers on the large-scale cultivation of Cannabis sativa in Colombia and Portugal under Good Manufacturing Practice (GMP) standards. Through its state-of-the-art greenhouse facilities and GMP-certified laboratories, Clever Leaves extracts and refines cannabinoids into high-purity active pharmaceutical ingredients (APIs) for the global medicinal cannabis market.
Since its founding in 2018, Clever Leaves has built a supply chain that spans seed-to-sale operations. In Colombia, the company leverages ideal growing conditions and a cost-efficient agricultural base to produce cannabinoid derivatives, while its European GMP facility in Portugal focuses on formulation, advanced extraction techniques and product development. These complementary sites enable Clever Leaves to deliver consistent quality and regulatory compliance across multiple product forms, including oils, tinctures and inhalable preparations.
Clever Leaves serves markets in Europe, Canada and Latin America, supplying APIs and finished dosage forms to pharmaceutical companies, contract manufacturers and research organizations. Its distribution channels extend into regulated markets such as Germany, the United Kingdom, Italy, Spain and Brazil, where local partners utilize Clever Leaves’ extracts in patient-accessible therapies. The company’s research and development efforts are aimed at broadening its product portfolio and supporting clinical studies that demonstrate the therapeutic value of cannabinoid-based treatments.
The organization is guided by a leadership team with deep expertise in agriculture, biotech and international regulatory affairs. Under the oversight of its executive management, Clever Leaves continues to pursue strategic expansions, regulatory approvals and partnerships designed to strengthen its global footprint. As a publicly traded entity on the OTC market, the company maintains a focus on sustainable growth and adherence to evolving compliance standards in the rapidly developing cannabis industry.
AI Generated. May Contain Errors.
